@article{JTD18366,
author = {Niels Steinebrunner and Wolfgang Stremmel and Karl H. Weiss},
title = {Ridinilazole—a novel antibiotic for treatment of Clostridium difficile infection},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {1},
year = {2018},
keywords = {},
abstract = {Clostridium difficile (C. difficile) infection has become a major health problem worldwide and is considered to be one of the most common hospital-acquired (nosocomial) infections with increasing incidence and severity (1). In Germany, the number of C. difficile infections (CDI) increased from 7 to 39 reported cases per 100,000 hospitalized patients between 2000 and 2004, with yet another doubling of numbers between 2004 and 2006 (2).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/18366}
}